This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.
Informed written consent will be taken from all subjects included in the study after approval of the study by the local ethical committee. All subjects will be subjected to thorough history taking with risk factors, medical histories, general clinical examination, local clinical examination, laboratory investigations as complete blood count and coagulation profile. Standardized anesthetic care will be provided according to institutional standards, which include fasting, antacid premedication and noninvasive hemodynamic monitoring After arrival in the operating room, patients will be positioned supine with left lateral tilt, pulse oximeter, ECG leads, non-invasive blood pressure cuff and cardiometry leads (4 surface ECG electrodes is attached to the left side of the neck and the lower thorax (approximately at the level of the xiphoid process) will be attached to patient for monitoring of blood pressure (bp), heart rate, fluid responsiveness (thoracic volume variations and stroke volume variations), cardiac index and systemic vascular resistance and values will be recorded as a baseline and every 10 minutes after intrathecal injection. 10 ml/kg/hr lactated ringer solution will be infused to all patients through an 18 gauge intravenous cannula for 30 minutes as a preload before spinal anesthesia then reduced to maintenance infusion of 6 ml/kg/hr. Patients will be then placed in sitting position. After skin disinfection and skin infiltration with lidocaine 1%, spinal anesthesia will be performed with 2ml 0.5% hyperbaric bupivacaine (10 mg) in addition to 0.5 ml fentanyl (25 μg) at L3-L4 or L4-L5. The patient will be then returned to the left-tilted supine position. The study drug regimen will be started immediately after intrathecal injection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
40
5 microgram bolus therapy
cardiac output, stroke volume and fluid responsiveness monitoring
2.5 microgram/min infusion
Faculty of Medicine, University Hospitals
Shibīn al Kawm, Menoufia, Egypt
throracic volume variations change from baseline
using cardiometry
Time frame: every 10 minutes up to 1 hour
cardiac index change from baseline
using cardiometry
Time frame: every 10 minutes up to 1 hour
systemic vascular resistance change from baseline
using cardiometry
Time frame: every 10 minutes up to 1 hour
stroke volume variation change from baseline
using cardiometry
Time frame: every 10 minutes and up to 1 hour
umblical cord gases sample
Time frame: in the first minute after delivery
APGAR score
score from 1 to 10 with the highest score better for neonatal outcome
Time frame: after 5 minutes and 10 minutes after delivery
Non invasive MEAN blood pressure
change from baseline
Time frame: every 10 minutes and up tp 1 hour
Heart rate
change from baseline
Time frame: every 10 minutes and up to 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.